Datapoint: Centene Completes Apixio Sale

Centene Corp. last week finalized its sale of Apixio, its artificial intelligence value-based care platform, to New Mountain Capital. “We are confident this transaction will best position Apixio to expand its impact as a leading artificial intelligence platform that enables value-based care programs across the country,” Centene CEO Sarah London said in a statement. The company has been working to divest its “non-core assets” since 2021. Centene’s insurance units currently enroll 21,669,643 people nationwide, with 69.2% enrolled in managed Medicaid, and 9.6% enrolled in Affordable Care Act marketplace products.

Source: AIS’s Directory of Health Plans

0 Comments
© 2024 MMIT
AIS Health Staff

AIS Health Staff

Related Posts

businessman-using-laptop-computer-and-digital-tablet-analyzing-sales-data-and-graph-chart
June 20

Datapoint: Ipsen’s Latest Accelerated Approval Will Challenge Intercept’s Ocaliva

Read More
businessman-using-laptop-computer-and-digital-tablet-analyzing-sales-data-and-graph-chart
June 18

Datapoint: Texas Won’t Halt Latest Medicaid Awards

Read More
businessman-using-laptop-computer-and-digital-tablet-analyzing-sales-data-and-graph-chart
June 17

Datapoint: Oscar Plans to Double Enrollment by 2027

Read More

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today